Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darbepoetin Alfa in Advanced NSCLC Anemia
NCT00858364Phase 3Terminated
- Sponsor
- Amgen
- Start
- Jul 2009
- Primary completion
- Jun 2017
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 37
01
Overview
A Phase 3 trial of darbepoetin alfa in anemia, sponsored by Amgen. Started Jul 2009; status: terminated.
02
Drugs
darbepoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00858364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00858364.